Kura Oncology, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $7.3M | $56.9M | $9.7M |
| FY2017 | $5.6M | $79.9M | $11.4M |
| FY2018 | $7.5M | $161.0M | $16.1M |
| FY2019 | $7.3M | $218.8M | $26.1M |
| FY2020 | $4.3M | $610.9M | $325.5M |
| FY2021 | — | $506.6M | $90.7M |
| FY2022 | $9.2M | $420.3M | $51.8M |
| FY2023 | $9.3M | $397.3M | $37.3M |
| FY2024 | $6.9M | $413.6M | $224.5M |
| FY2025 | $9.7M | $174.1M | $149.1M |